ACHE and Alzheimer disease: Selective inhibition of BChE activity could be advantageous for the treatment of advanced AD, because it may circumvent classical cholinergic toxicity like nausea and vomiting, which are common side effects of AChE inhibition; however, it can also lead to adverse peripheral side effects [7].